365
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments

, , , &
Pages 545-560 | Received 11 Oct 2015, Accepted 27 Nov 2015, Published online: 31 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Winfried Alsdorf, Christoph Seidel, Carsten Bokemeyer & Christoph Oing. (2019) Current pharmacotherapy for testicular germ cell cancer. Expert Opinion on Pharmacotherapy 20:7, pages 837-850.
Read now

Articles from other publishers (11)

Christoph Oing & Carsten Bokemeyer. (2021) Aktuelle Therapiekonzepte bei Keimzelltumoren des MannesCurrent treatment concepts for testicular germ cell cancer. Der Onkologe 27:8, pages 833-846.
Crossref
Axel Heidenreich, David Pfister & Pia Paffenholz. (2021) Salvage management of patients with relapsing testicular germ cell tumors. Current Opinion in Urology 31:3, pages 206-213.
Crossref
Ryujiro Hara, Makoto Onizuka, Sawako Shiraiwa, Kaito Harada, Yasuyuki Aoyama, Daisuke Ogiya, Masako Toyosaki, Rikio Suzuki, Sinichiro Machida, Ken Ohmachi, Yoshiaki Ogawa, Hiroshi Kawada, Shigeki Watanabe, Akira Miyajima, Ryota Masuda, Masayuki Iwazaki, Mikio Mikami, Takashi Koike, Hiroyuki Mochizuki & Kiyoshi Ando. (2021) The Role of Hypertension and Renin-angiotensin-aldosterone System Inhibitors in Bleomycin-induced Lung Injury. Clinical Lymphoma Myeloma and Leukemia 21:4, pages e321-e327.
Crossref
Marek Ussowicz, Monika Mielcarek-Siedziuk, Jakub Musiał, Mateusz Stachowiak, Jadwiga Węcławek-Tompol, Dorota Sęga-Pondel, Jowita Frączkiewicz, Joanna Trelińska & Anna Raciborska. (2020) Melphalan, Etoposide, and Carboplatin Megatherapy with Autologous Stem Cell Transplantation in Children with Relapsing or Therapy-Resistant Extracranial Germ-Cell Tumors—A Retrospective Analysis. Cancers 12:12, pages 3841.
Crossref
Rui Xu, Zhaowei Xu, Yuanchun Si, Xin Xing, Qingdong Li, Jianmin Xiao, Bin Wang, Geng Tian, Ling Zhu, Zhengyan Wu & Guilong Zhang. (2020) Oxygen Vacancy Defect-Induced Activity Enhancement of Gd Doping Magnetic Nanocluster for Oxygen Supplying Cancer Theranostics. ACS Applied Materials & Interfaces 12:33, pages 36917-36927.
Crossref
Andrea Necchi, Gennady Bratslavsky, Robert J. Corona, Jon H. Chung, Sherri Z. Millis, Julia A. Elvin, Jo-Anne Vergilio, James Suh, Shakti Ramkissoon, Eric Severson, Sugganth Daniel, Jonathan K. Killian, Siraj M. Ali, Alexa B. Schrock, Prasanth Reddy, Vincent A. Miller, Allison Welsh, Laurie M. Gay & Jeffrey S. Ross. (2020) Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy. European Urology Focus 6:1, pages 122-130.
Crossref
Liang Cheng, Peter Albers, Daniel M. Berney, Darren R. Feldman, Gedske Daugaard, Timothy Gilligan & Leendert H. J. Looijenga. (2018) Testicular cancer. Nature Reviews Disease Primers 4:1.
Crossref
Irbaz bin Riaz, Muhammad Umar, Umar Zahid, Muhammad Husnain, Ahmad Iftikhar, Ali McBride, Jawad Bilal, Asad Javed, Sara Akbar, Parminder Singh, Zeeshan Ali, Qurat Ul Ain Riaz Sipra, Farva Razia Gondal, Frederick Ahman & Faiz Anwer. (2018) Role of one, two and three doses of high-dose chemotherapy with autologous transplantation in the treatment of high-risk or relapsed testicular cancer: a systematic review. Bone Marrow Transplantation 53:10, pages 1242-1254.
Crossref
Christoph Oing, Christoph Seidel, Winfried H. Alsdorf & Carsten Bokemeyer. (2016) Cisplatin-refraktäre KeimzelltumorenCisplatin-refractory germ cell tumors. Der Onkologe 23:2, pages 123-128.
Crossref
Diana Cláudia Gouveia Alves Pinto, Ana Maria Loureiro Seca & Artur Manuel Soares Silva. 2017. Anticancer Plants: Clinical Trials and Nanotechnology. Anticancer Plants: Clinical Trials and Nanotechnology 105 151 .
. (2016) Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial. Oncology Research and Treatment 39:9, pages 553-556.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.